Interim results for BCMA T-cell engager alnuctamab (CC-93269) in RRMM VJHemOnc – Video Journal of Hematology & HemOnc 2:24 5 years ago 78 Далее Скачать
Alnuctamab, a BCMA x CD3 T-Cell Engager, in Pts with Relapsed/Refractory Multiple Myeloma International Myeloma Foundation 8:36 1 year ago 570 Далее Скачать
Q&A | How to sequence CAR T-cell therapy and bispecific antibodies in R/R MM Multiple Myeloma Hub 4:36 3 months ago 207 Далее Скачать
BCMA 2+1 T-cell engager CC-93269 in patients with R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:58 4 years ago 74 Далее Скачать
B-Cell Maturation Antigen (BCMA) 2+1 T Cell Engager CC-93269 in Patients with RR Multiple Myeloma International Myeloma Foundation 3:03 5 years ago 298 Далее Скачать
Symposium | How to sequence CAR T-cell therapy and bispecific antibodies in R/R multiple myeloma Multiple Myeloma Hub 23:53 4 months ago 528 Далее Скачать
Alnuctamab, a BCMA x CD3 TCE, in the treatment of multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:02 9 months ago 107 Далее Скачать
Subcutaneous alnuctamab in patients with R/R multiple myeloma: the results of a Phase I trial VJHemOnc – Video Journal of Hematology & HemOnc 2:46 11 months ago 159 Далее Скачать
Interim results of the ProMMise trial: belantamab + cyclophosphamide & dexamethasone in R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:53 1 day ago 27 Далее Скачать
What is BCMA? #myeloma HealthTree University for Multiple Myeloma 3:36 9 months ago 585 Далее Скачать
Is CC-93269, a novel BCMA T-cell engager, safe and efficacious for patients with RRMM? Multiple Myeloma Hub 2:19 5 years ago 145 Далее Скачать
What are the differences between CAR T-cell therapy and bispecific antibodies? International Myeloma Foundation 4:01 1 year ago 2 946 Далее Скачать
Teclistamab, a BCMA × Cd3 Bispecific Antibody, in Pts with RRMM: Updated Phase 1 Results International Myeloma Foundation 9:57 3 years ago 1 156 Далее Скачать
Idecabtagene vicleucel, a BCMA-directed CAR T cell therapy, in RRMM: Updated KarMMa results International Myeloma Foundation 7:49 3 years ago 557 Далее Скачать
Dr. Michael Chu on CC-93269, a bispecific T-cell engager (BiTE) targeting BCMA and CD3, shows... NE Live 6:21 4 years ago 116 Далее Скачать
Evaluation of AMG 420, an anti-BCMA bispecific T-cell engager (BiTE) immunotherapy in patients w... ecancer 7:13 5 years ago 368 Далее Скачать
Updated phase 1 results of teclistamab, a BCMA × CD3 bispecific antibody, in RRMM International Myeloma Foundation 7:25 3 years ago 414 Далее Скачать
Efficacy and safety of elranatamab BCMA-CD3 bispecific antibody, in patients with RRMM International Myeloma Foundation 7:06 3 years ago 1 093 Далее Скачать
Exciting results for BCMA/CD3 bispecific elranatamab (PF-3135) in R/R MM VJHemOnc – Video Journal of Hematology & HemOnc 3:34 4 years ago 680 Далее Скачать
Seminar 7: Bispecific T-cell Engagers (BiTEs) in Myeloma Canadian Myeloma Research Group 1:28:30 6 months ago 148 Далее Скачать
